Document is current
Any future updates will be listed below
-
Authors
Lloyd, Maxwell R.
Jhaveri, Komal
Kalinsky, Kevin
Bardia, Aditya
Wander, Seth A. https://orcid.org/0000-0002-4127-4708
- License Information
-
More Information
Article History
Accepted: 31 July 2024
First Online: 23 August 2024
Competing interests
: K.J. has had consultant or advisory board roles for AbbVie, AstraZeneca, Blueprint Medicine, Daiichi Sankyo, Eisai, Genentech, Gilead, Lilly/Loxo Oncology, Menarini/Stemline, Novartis, Pfizer, Scorpion Therapeutics, Sun Pharma Advanced Research Company Ltd, Taiho Oncology and Zymeworks, and has received research funding support through their institution from AstraZeneca, Blueprint Medicines, Context Therapeutics, Genentech, Immunomedics/Gilead, Lilly/Loxo Oncology, Merck Pharmaceuticals, Novartis, Pfizer, Puma Biotechnology, Scorpion Therapeutics and Zymeworks. K.K. has had consultant or advisory board roles for Astra Zeneca, Daiichi Sankyo, eFFECTOR Therapeutics, Genentech/Roche, Gilead, Lilly, Menarini Silicon Biosystems, Merck, Mersana, Myovant Sciences, Novartis, Prelude Therapeutics, Puma Biotechnology, RayzeBio, Regor, Relay Therapeutics, Seattle Genetics and Takeda; has received research funding support through their institution from Ascentage, AstraZeneca, Daichi Sankyo, Genentech/Roche, Lilly, Novartis and Seattle Genetics; and has a spouse who owns stock from ADC Therapeutics and EQRX (as a prior employee). A.B. has had consultant or advisory board roles for Astra Zeneca, Daiichi Pharma, Eli Lilly, Foundation Medicine, Genentech, Immunomedics/Gilead, Merck, Novartis, Pfizer, Phillips, Radius Health and Sanofi, and has received research funding support through their institution from AstraZeneca, Daiichi Pharma, Eli Lilly, Genentech, Immunomedics/Gilead, Merck, Novartis, Pfizer, Radius Health and Sanofi. S.A.W. has had consultant or advisory board roles for AstraZeneca, Biovica, Eli Lilly, Foundation Medicine, Genentech, Hologic, Novartis, Pfizer, Puma Biotechnology and Veracyte; has education or speaking roles for 2ndMD, Eli Lilly and Guardant Health; and has received research funding support through their institution from Eli Lilly, Genentech, Nuvation Bio, Pfizer, Regor Therapeutics and Sermonix. M.R.L. declares no competing interests.
